Belongs to

• Gynecology Disease Management Team

Types of Work

["2022"]

[[["Journal Articles",932],["Meeting Abstracts",831],["Reviews",49],["Book Sections",38],["Editorials",29],["Guidelines",19],["Correspondences",7],["Research Letters",1]]]

[1906]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• humans
• major clinical study
• middle aged
• ovarian cancer

Recent Works

1. Randomized study evaluating optimal dose, efficacy, and safety of E7386 plus lenvatinib versus treatment of physician's choice in advanced/recurrent endometrial carcinoma previously treated with platinum-based chemotherapy and immune checkpoint inhibitors

   Journal Article

   Eskander, R. N.; Lee, J. Y.; Mirza, M. R.; Lorusso, D.; MacKay, H.; Ray-Coquard, I.; Oaknin, A.; Gonzalez-Martin, A.; Hasegawa, K.; Corr, B. R.; more...
   International Journal of Gynecological Cancer (2025)

   Fulltext@MSK | Save
2. Whole-genome sequencing-based characterization of endometrial serous carcinoma

   Journal Article

   Andres, S.; Brown, D. N.; da Cruz Paula, A.; Aghajanian, C.; Abu-Rustum, N. R.; Ellenson, L. H.; Weigelt, B.
   Gynecologic Oncology (2025)

   Fulltext@MSK | Save
3. Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?

   Journal Article

   Sia, T. Y.; Moufarrij, S.; Milani, J.; Kane, S.; Zhou, Q.; Fong, C.; Khurram, A.; Kemel, Y. M.; Sheehan, M.; Latham, A.; more...
   Gynecologic Oncology (2025)

   Fulltext@MSK | Save